ATE339511T1 - Natürliche oder synthetische retroelement- sequenzen, die die insertion von nukleotiden in eukaryotische zellen erlauben - Google Patents

Natürliche oder synthetische retroelement- sequenzen, die die insertion von nukleotiden in eukaryotische zellen erlauben

Info

Publication number
ATE339511T1
ATE339511T1 AT96927085T AT96927085T ATE339511T1 AT E339511 T1 ATE339511 T1 AT E339511T1 AT 96927085 T AT96927085 T AT 96927085T AT 96927085 T AT96927085 T AT 96927085T AT E339511 T1 ATE339511 T1 AT E339511T1
Authority
AT
Austria
Prior art keywords
synthetic
natural
nucleotides
allow
eukaryotic cells
Prior art date
Application number
AT96927085T
Other languages
English (en)
Inventor
Andre Choulika
Jean-Francois Nicolas
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE339511T1 publication Critical patent/ATE339511T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96927085T 1995-08-07 1996-07-25 Natürliche oder synthetische retroelement- sequenzen, die die insertion von nukleotiden in eukaryotische zellen erlauben ATE339511T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509587A FR2737731B1 (fr) 1995-08-07 1995-08-07 Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote

Publications (1)

Publication Number Publication Date
ATE339511T1 true ATE339511T1 (de) 2006-10-15

Family

ID=9481767

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96927085T ATE339511T1 (de) 1995-08-07 1996-07-25 Natürliche oder synthetische retroelement- sequenzen, die die insertion von nukleotiden in eukaryotische zellen erlauben
AT06018991T ATE477326T1 (de) 1995-08-07 1996-07-25 Sequenzen von natürlischen oder synthetischen retroelementen, die die insertion von nukleotiden sequenzen in eukaryotische zellen erlauben

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06018991T ATE477326T1 (de) 1995-08-07 1996-07-25 Sequenzen von natürlischen oder synthetischen retroelementen, die die insertion von nukleotiden sequenzen in eukaryotische zellen erlauben

Country Status (12)

Country Link
US (2) US6200800B1 (de)
EP (2) EP1760154B1 (de)
JP (2) JP4173543B2 (de)
AT (2) ATE339511T1 (de)
CA (1) CA2226301C (de)
DE (2) DE69636546T2 (de)
DK (1) DK0843732T3 (de)
ES (1) ES2276407T3 (de)
FR (1) FR2737731B1 (de)
HK (1) HK1105662A1 (de)
PT (1) PT843732E (de)
WO (1) WO1997006271A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737731B1 (fr) * 1995-08-07 1997-10-10 Pasteur Institut Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote
US5928914A (en) * 1996-06-14 1999-07-27 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Methods and compositions for transforming cells
US6534314B1 (en) 1996-06-14 2003-03-18 Massachusetts Institute Of Technology Methods and compositions for transforming cells
US6410317B1 (en) * 1999-07-14 2002-06-25 Clontech Laboratories, Inc. Recombinase-based methods for producing expression vectors and compositions for use in practicing the same
GB2355459B (en) * 1999-11-29 2001-09-26 Isis Innovation A dominant conditional lethal genetic system
US20040231006A1 (en) * 2000-04-12 2004-11-18 Silver Daniel P. Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
CA2405768A1 (en) 2000-04-12 2001-10-25 Dana-Farber Cancer Institute Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
US7101541B2 (en) 2000-05-19 2006-09-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution
GB2402675B (en) * 2003-05-12 2008-02-20 Oxitec Ltd Resistance dilution
GB2403475B (en) * 2003-07-01 2008-02-06 Oxitec Ltd Stable integrands
GB2404382B (en) 2003-07-28 2008-01-30 Oxitec Ltd Pest control
ATE537254T1 (de) * 2005-07-05 2011-12-15 Chemo Sero Therapeut Res Inst Mutanter transposonvektor und verwendung davon
GB2443186A (en) 2006-10-25 2008-04-30 Oxitec Ltd Expression system for mediating alternative splicing
GB2500113A (en) 2012-03-05 2013-09-11 Oxitec Ltd Arthropod male germline gene expression system
GB201303932D0 (en) 2013-03-05 2013-04-17 Oxitec Ltd Muscle actin promoter
GB2526867A (en) 2014-06-05 2015-12-09 Oxitec Ltd Gene expression system
US11827876B2 (en) 2016-08-12 2023-11-28 Oxitec Ltd. Self-limiting, sex-specific gene and methods of using

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61502885A (ja) 1984-08-06 1986-12-11 ヒル．ロバ−ト ロツク式チユ−ブ巻取り装置
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
DE3876327D1 (de) * 1987-07-21 1993-01-14 Du Pont Merck Pharma Verfahren fuer die herstellung von in tierischen zellen stabilen und lebensfaehigen rekombinanten viralen vektoren.
FR2629469B1 (fr) * 1988-03-31 1990-12-21 Pasteur Institut Retrovirus recombinant defectif, son application a l'integration de sequences codantes pour des proteines determinees dans le genome de cultures cellulaires infectables par le retrovirus sauvage correspondant et adns recombinants pour la production de ce retrovirus recombinant
US5658775A (en) * 1988-05-17 1997-08-19 Sloan-Kettering Institute For Cancer Research Double copy retroviral vector
JP3249516B2 (ja) * 1990-10-31 2002-01-21 ソマティクス セラピー コーポレイション 遺伝子治療のためのレトロウイルスのベクター
US5629159A (en) * 1995-06-07 1997-05-13 California Institute Of Technology Immortalization and disimmortalization of cells
FR2737731B1 (fr) * 1995-08-07 1997-10-10 Pasteur Institut Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote

Also Published As

Publication number Publication date
JP4173543B2 (ja) 2008-10-29
ATE477326T1 (de) 2010-08-15
PT843732E (pt) 2007-01-31
US6200800B1 (en) 2001-03-13
HK1105662A1 (en) 2008-02-22
DK0843732T3 (da) 2007-01-22
EP1760154B1 (de) 2010-08-11
DE69636546T2 (de) 2007-08-02
JPH11510391A (ja) 1999-09-14
WO1997006271A1 (fr) 1997-02-20
EP1760154A2 (de) 2007-03-07
CA2226301C (fr) 2011-04-19
ES2276407T3 (es) 2007-06-16
EP1760154A3 (de) 2007-03-14
CA2226301A1 (fr) 1997-02-20
FR2737731B1 (fr) 1997-10-10
JP4482578B2 (ja) 2010-06-16
EP0843732B1 (de) 2006-09-13
US20060269522A1 (en) 2006-11-30
DE69636546D1 (de) 2006-10-26
JP2008086321A (ja) 2008-04-17
FR2737731A1 (fr) 1997-02-14
DE69638235D1 (de) 2010-09-23
EP0843732A1 (de) 1998-05-27

Similar Documents

Publication Publication Date Title
ATE339511T1 (de) Natürliche oder synthetische retroelement- sequenzen, die die insertion von nukleotiden in eukaryotische zellen erlauben
Higuchi et al. DNA sequences from the quagga, an extinct member of the horse family
EP0331939A3 (de) Verfahren und Zusammensetzungen zum Widerstand gegen Retroviralinfektionen
ES2010727A6 (es) Metodo para producir lineas celulares que producen anticuerpos monoclonales reactivos frente a determinantes antigenicos de gp110 o de p25 de hiv.
DE69834056D1 (de) De novo oder "universaler" sequenzierungs-array
ES2064077T3 (es) Integracion estable de adn en genomas bacterianos.
ATE520783T1 (de) Lentivirale vektoren
ES2061661T3 (es) Inhibidores de la expresion virica.
DE59611371D1 (de) Verfahren zur Herstellung von Erythropoietin frei von tierischen Proteinen
PT80631B (de) Verfahren zur herstellung von thrombin-inhibitoren
DK0550665T3 (da) Ny neurotrofisk faktor
DE69535125D1 (de) Impstoff gegen felines immunodefizienz-virus
ATE391175T1 (de) Multidrug resistenz gen
Hasegawa et al. On the antisymmetry of the amino acid code table
RU98100921A (ru) Праймеры для обнаружения вич-1
EP0854197A3 (de) Primern zum Nachweis von HIV-1
DE3751368D1 (de) gentechnische Herstellung von Faktor XIIIa.
DE69534948D1 (de) Retrovirale vektoren zur expression in embryonalen zellen
ATE139265T1 (de) Bestimmung des geschlechts bei wiederkäuern unter verwendung von gamma-chromosom-spezifischen polynukleotiden
DE69941836D1 (de) Verfahren zur Verabreichng von Nukleinsäuren in Zellen in vitro oder ex vivo
DK0857220T3 (da) Sekvensmodifikation af oligonucleotidprimere til manipulering af ikke-templateret nucleotidaddition
DK631387D0 (da) Virusvektor
Chen et al. Participation of 7S L RNA in Reverse Transcription by an Avian Retrovirus
De la Cruz STUDIES ON THE GENETIC FUNCTIONALITY OF THE MITOCHONDRIAL GENOME FROM THE KINETOPLASTID PROTOZOAN, LEISHMANIA TARENTOLAE: IDENTIFICATION OF SEVERAL MITOCHONDRIAL PROTEIN GENES AND SECONDARY STRUCTURE OF THE UNUSUAL 12S AND 9S RIBOSOMAL RNAS (TRYPANOSOME, RECOMBINANT DNA, DNA SEQUENCE, EVOLUTION)
JPS6420088A (en) Preparation of single stranded dna

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0843732

Country of ref document: EP